http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103601809-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29 |
| filingDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103601809-B |
| titleOfInvention | A kind of HCV multi-epitope peptide and truncated-type NS3, DC anakmetomeres EDA recombinant protein vaccine and application thereof |
| abstract | The invention discloses a kind of HCV multi-epitope peptide and truncated-type NS3, DC anakmetomeres EDA recombiant protein and application thereof, this recombinant protein vaccine includes following EDA, Δ NS3 and 3 HCVmulti epitopes: its nucleotide sequence is as shown in SEQ.ID. NO.1.HCV EDA Δ NS3 VAL 44 albumen can induce specific humoral immunoresponse(HI) and T cell immunne response, T cell can produce rapidly IFN γ and produce efficient CTL after specific antigen stimulates, this kind of HCV multi-epitope peptide and be probably comparatively ideal HCV preventing/treating candidate vaccine with truncated-type NS3, DC anakmetomeres EDA recombinant protein vaccine. |
| priorityDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.